NCS Specialty Pharmacy Distinction in Oncology
NEBRASKA CANCER SPECIALISTS SPECIALTY PHARMACY ACHIEVES ACHC DISTINCTION IN ONCOLOGY
Nebraska Cancer Specialists (NCS) is proud to announce it has been awarded Specialty Pharmacy Accreditation with Distinction in Oncology by Accreditation Commission for Health Care (ACHC). By earning this accreditation, NCS joins an elite, limited group of specialty pharmacies who have been recognized by ACHC for providing cancer patients with exceptional and quality care.
Omaha, NE – June 1st, 2020 The ACHC Specialty Pharmacy Accreditation with Distinction in Oncology recognizes specialty pharmacies who have demonstrated an outstanding commitment to ensuring cancer patients receive oral cancer drugs and ancillary oral therapies in a safe, reliable, accessible, and affordable environment that is integrated with their overall plan of care. Achieving ACHC Specialty Pharmacy Accreditation with Distinction in Oncology validates Nebraska Cancer Specialists achievement in meeting and exceeding the highest standards of quality in the delivery of compassionate, personalized cancer care for patients.
“Achieving this accreditation demonstrates our commitment to providing NCS patients with the highest level of pharmaceutical care. Our ability to meet and exceed ACHC standards, as well as receiving our certification of distinction in oncology, provides proof that our staff is dedicated to serving oncology/hematology patients requiring highly specialized therapies. This is yet another service we are proud to provide to our patients,” said Michael Brodersen, Pharm D, BCOP Nebraska Cancer Specialists’ Outpatient Pharmacist.
ACHC is a nonprofit organization that has stood as a symbol of quality and excellence since 1986. Accreditation by ACHC reflects an organization’s dedication and commitment to meeting quality standards that facilitate a higher level of performance and patient care. For more information about ACHC visit http://www.achc.org
About Nebraska Cancer Specialists
Nebraska Cancer Specialists is the regional leader in Community Oncology, which refers to the practice of treating patients in a private outpatient setting. The practice consists of 14 medical oncology and hematology, nuclear medicine and radiation oncology physicians, a robust clinical trial research department, and the first dedicated Theranostics center in the region, thus giving our patients access to newer, cutting edge options. In addition to ACHC accreditation, NCS has been recognized with the Quality Oncology Practice Initiative QOPI certification that recognizes outpatient hematology-oncology practices in the United States for high-quality care. For more information, visit nebraskacancer.com.